Perry, GA, United States of America

Berno Pettersson


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 211(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Berno Pettersson in Transdermal Delivery Systems

Introduction

Berno Pettersson is an accomplished inventor based in Perry, Georgia, known for his significant contributions to the field of transdermal delivery systems. With a total of two patents to his name, Pettersson has focused on developing compositions that enhance the delivery of pharmaceutically active agents through the skin.

Latest Patents

Pettersson's latest patents include innovative methods for formulating transdermal delivery systems (TDS) that are both rapid and non-irritating. These systems can be applied as either open (liquid, gel) or closed (patch) articles. The TDS is designed to utilize a specific active agent, which determines the selection of solvents, solvent modifiers, solute modifiers, and skin stabilizers. This careful selection allows the medicament to form a true solution that effectively crosses the skin barrier. Additionally, the TDS may incorporate a source of cellular energy to induce CAMP or cGMP, thereby improving the delivery of active agents with a molecular weight greater than 340 Daltons and increasing the dosage above 0.25 mg/day.

Career Highlights

Berno Pettersson has made notable strides in his career, particularly through his work at Transdermal Technologies, Inc. His innovative approach to transdermal delivery has positioned him as a key figure in the pharmaceutical industry, contributing to advancements that enhance patient care and treatment efficacy.

Collaborations

Pettersson collaborates with Kenneth B. Kirby, leveraging their combined expertise to further develop and refine transdermal delivery technologies.

Conclusion

Berno Pettersson's work in transdermal delivery systems exemplifies the impact of innovation in pharmaceuticals. His patents reflect a commitment to improving the efficacy of drug delivery methods, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…